Daily non-political popular news in brief.

Women on osteoporosis drug can discontinue use with no risk

A long-term study of the most widely used osteoporosis drug has found that many women can discontinue the drug after five years without increasing their fracture risk for as long as five more years.

Read more »

Keywords: women, osteoporosis, drug, discontinue, risk, osteoporosi

« Previous | Next »

Similar news on "Women on osteoporosis drug can discontinue use with no risk":

1. Women may be able to 'take break' from osteoporosis drug without losing benefit
   12-26-2006 · EurekAlert!
   Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.
   Similar news · Read more »
   
2. Estrogen is important for bone health in men as well as women
   05-10-2007 · EurekAlert!
   Although women are four times more likely than men to develop osteoporosis, or porous bone, one in 12 men also suffer from the disease, which can lead to debilitating fractures. In women, low estrogen levels after menopause have been considered an important risk factor for this disorder. Now research at Washington University School of Medicine in St. Louis has shown that low amounts of active estrogen metabolites also can increase the risk of osteoporosis in men.
   Similar news · Read more »
   
3. Depression linked to bone-thinning in premenopausal women
   11-26-2007 · EurekAlert!
   Even in young women, depression is as potent a risk factor for osteoporosis as are low calcium intake, smoking, and lack of exercise, NIH researchers have found. Imbalances in the immune system appear to be involved. Depression generally isn't on clinicians' radar screens as a risk factor for bone-thinning -- but it should be.
   Similar news · Read more »
   
4. Alendronate can help prevent bone fractures in many postmenopausal women
   01-22-2008 · EurekAlert!
   Giving 10mg per day of the bisphosphate drug alendronate to women after their menopause can help prevent loss of bone mass, reducing their risk of fractures, a Cochrane Review has found. This finding applies to women who have started to lose their bone mass but have no fractures (primary prevention), as well as those who have lost significant bone mass and/or have had fractures (secondary prevention).
   Similar news · Read more »
   
5. New study shows Actonel almost halves the risk of hip fractures compared to alendronate
   11-17-2006 · EurekAlert!
   Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel® (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. These results were published today in the peer-reviewed journal Osteoporosis International.1
   Similar news · Read more »
   
6. New doctors' test kit to help prevent debilitating osteoporosis
   05-22-2007 · EurekAlert!
   Men and women at risk of developing osteoporosis will soon be working closely with their doctors to prevent the onset of this debilitating and often deadly disease thanks to a new Garvan research project funded by MBF Foundation.
   Similar news · Read more »
   
7. High-trauma fractures in older adults linked to osteoporosis, increased risk of another fracture
   11-27-2007 · EurekAlert!
   Contrary to a widely held assumption, high-trauma nonspine fractures in older women and men, such as from a car crash, are associated with low bone mineral density and an increased risk of a subsequent fracture, according to a study in the Nov. 28 issue of JAMA. These findings suggest that older adults who experience these fractures should be evaluated for osteoporosis.
   Similar news · Read more »
   
8. Lower IQ found in children of women who took epilepsy drug
   05-03-2007 · EurekAlert!
   Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ, according to research presented at the American Academy of Neurology's 59th annual Meeting in Boston, April 28-May 5, 2007.
   Similar news · Read more »
   
9. World AIDS Day: HIV prevention, diagnosis and treatment
   11-30-2007 · EurekAlert!
   On December 1, PLoS Medicine is publishing a collection of research articles and commentary, as well as an editorial to mark World AIDS Day 2007. In this release: Men who have sex with men face high AIDS risk in developing countries; Women disclose their HIV status at three key times around childbirth; Unnoticed mutation in AIDS virus can cause drug resistance; and HIV confirmatory test can also estimate recent infections.
   Similar news · Read more »
   
10. Women up to age 30 at risk for bone loss, study finds
    06-04-2007 · EurekAlert!
    Women who follow strict exercise and diet regimens may harm their body's ability to form new bone, which can lead to osteoporosis later in life. Researchers recommend that the more women exercise, the more they need to eat to stay healthy.
    Similar news · Read more »